Germany: Rudischhauser becomes latest addition to Gilde’s Surgical Instrument Contract Manufacturing Group

Thematic investor Gilde Healthcare has expanded its Surgical Instrument Contract Manufacturing Group (the Group) with the acquisition of Germany-based medtech Rudischhauser Surgical Instruments Manufacturing, a specialist manufacturer of complex surgical instruments and implants with a focus on the spine, orthopaedics, and traumatology space.

“The acquisition of Rudischhauser marks another important step in building our vision of a leading surgical instrument contract manufacturing group,” said Rafael Natanek, general partner at Gilde Healthcare Private Equity.

Rudischhauser joins the Group alongside Chr. Diener and Koscher & Würtz, bringing the combined organisation to approximately 350 employees. It broadens the Group’s portfolio of precision surgical instruments and strengthens opportunities for best practice, operational and knowledge sharing across its companies.

Founded in 1954, Rudischhauser is known as a specialist in complex, reusable surgical instruments and has built long‑standing customer relationships based on quality, precision, and trust.

“We are thrilled to join the Group and view this partnership as an exciting next chapter for our company,” said Steffen Rudischhauser, owner and managing director of Rudischhauser. “It ensures the continuity of our high quality and craftsmanship while providing the scale and resources needed for future growth. The potential for our company to benefit from synergies within the group, particularly in IT and quality management, was another key consideration in taking this step.”

While Steffen Rudischhauser will remain with the company as managing director, the second shareholder, Sandra Rudischhauser, will leave the company after a transition period.

Gilde Healthcare established the Group through the acquisitions of Chr. Diener (2022) and Koscher & Würtz (2023). As consolidation in the surgical instrument manufacturing sector accelerates, Gilde Healthcare intends to continue expanding the Group through both strategic acquisitions and organic growth.

“Welcoming Rudischhauser to the Group represents a major milestone in our growth journey,” said Dr Christian Stark, CEO of the Group. “We look forward to continuing the Group’s growth organically and through further acquisitions of specialised medical device manufacturers.”

Goodwin (Winfried Carli, Daniel Wagner, Rina Omura) advised Gilde Healthcare.

Greenberg Traurig – led by Henrik Armah – advised Gilde-backed Surgical Precisions Instruments on the acquisition.

Press release: Gilde Healthcare backed MedTech Group acquires precision surgical instruments and implants contract manufacturer Rudischhauser – Gilde Healthcare